280 related articles for article (PubMed ID: 29264946)
1. Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.
Wang Z; Wu Z; Liu J; Zhang W
Expert Opin Drug Deliv; 2018 Apr; 15(4):379-395. PubMed ID: 29264946
[TBL] [Abstract][Full Text] [Related]
2. The importance of nanoparticle shape in cancer drug delivery.
Truong NP; Whittaker MR; Mak CW; Davis TP
Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
[TBL] [Abstract][Full Text] [Related]
3. Actively targeted nanocarriers for drug delivery to cancer cells.
Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
5. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
6. Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
Mathaes R; Winter G; Besheer A; Engert J
Expert Opin Drug Deliv; 2015 Mar; 12(3):481-92. PubMed ID: 25327886
[TBL] [Abstract][Full Text] [Related]
7. Deep penetration of nanoparticulate drug delivery systems into tumors: challenges and solutions.
Li L; Sun J; He Z
Curr Med Chem; 2013; 20(23):2881-91. PubMed ID: 23651305
[TBL] [Abstract][Full Text] [Related]
8. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
Bhagat M; Halligan S; Sofou S
Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
[TBL] [Abstract][Full Text] [Related]
11. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
12. 'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.
Fang Z; Wan LY; Chu LY; Zhang YQ; Wu JF
Expert Opin Drug Deliv; 2015; 12(12):1943-53. PubMed ID: 26193970
[TBL] [Abstract][Full Text] [Related]
13. Anisotropic noble metal nanoparticles: Synthesis, surface functionalization and applications in biosensing, bioimaging, drug delivery and theranostics.
Paramasivam G; Kayambu N; Rabel AM; Sundramoorthy AK; Sundaramurthy A
Acta Biomater; 2017 Feb; 49():45-65. PubMed ID: 27915023
[TBL] [Abstract][Full Text] [Related]
14. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
16. Calcium carbonate nanoparticles as cancer drug delivery system.
Maleki Dizaj S; Barzegar-Jalali M; Zarrintan MH; Adibkia K; Lotfipour F
Expert Opin Drug Deliv; 2015; 12(10):1649-60. PubMed ID: 26005036
[TBL] [Abstract][Full Text] [Related]
17. The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles.
Jindal AB
Int J Pharm; 2017 Oct; 532(1):450-465. PubMed ID: 28917985
[TBL] [Abstract][Full Text] [Related]
18. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
19. Janus nanoparticles: materials, preparation and recent advances in drug delivery.
Tran LT; Lesieur S; Faivre V
Expert Opin Drug Deliv; 2014 Jul; 11(7):1061-74. PubMed ID: 24811771
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
